Brain Insulin Dysregulation: Implication for Neurological and Neuropsychiatric Disorders

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Molecular Neurobiology

• Publication date

  2013-01-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12035-013-8404-zPMID 23335160
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The metabolic syndrome in schizophrenia: is inflammation a contributing cause?

  2012cited by this paper
• Paeonol Attenuates Microglia-Mediated Inflammation and Oxidative Stress–Induced Neurotoxicity in Rat Primary Microglia and Cortical Neurons

  2012cited by this paper
• Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia

  2012cited by this paper
• Hyperglycemic chorea-ballism or acute exacerbation of Huntington's chorea? Huntington's disease unmasked by diabetic ketoacidosis in type 1 diabetes mellitus.

  2012cited by this paper
• Toll‐like receptors 2 and 4 impair insulin‐mediated brain activity by interleukin‐6 and osteopontin and alter sleep architecture

  2012cited by this paper
• Synaptic dysfunction in schizophrenia.

  2012cited by this paper
• The renin‐angiotensin system: a link between obesity, inflammation and insulin resistance

  2012cited by this paper
• Inflammation in schizophrenia.

  2012cited by this paper
• A mitochondrial etiology of Alzheimer and Parkinson disease.

  2012cited by this paper
• Is abnormal glucose tolerance in antipsychotic-naive patients with nonaffective psychosis confounded by poor health habits?

  2012cited by this paper
• Targeting IL-1 in depression

  2012cited by this paper
• Inflammatory mechanisms in major depressive disorder

  2011cited by this paper
• Diabetes and Risk of Parkinson’s Disease

  2011cited by this paper
• Protective effect of pioglitazone, a PPARγ ligand, in a 3 nitropropionic acid model of Huntington's disease.

  2011cited by this paper
• No Effect of Single-Dose Intranasal Insulin Treatment on Verbal Memory and Sustained Attention in Patients With Schizophrenia

  2011cited by this paper
• Alzheimer’s Disease: The Challenge of the Second Century

  2011cited by this paper
• Suppressing inflammatory cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced Huntington's disease-like alterations in rats.

  2011cited by this paper
• Possible regulatory factors for intra-abdominal fat mass in a rat model of Parkinson's disease.

  2011cited by this paper
• Low-grade hypothalamic inflammation leads to defective thermogenesis, insulin resistance, and impaired insulin secretion.

  2011cited by this paper
• Insulin resistance impairs nigrostriatal dopamine function.

  2011influential reference
• Tyrosine hydroxylase and regulation of dopamine synthesis.

  2011cited by this paper
• The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys

  2011cited by this paper
• Apolipoprotein E reduces food intake via PI3K/Akt signaling pathway in the hypothalamus.

  2011cited by this paper
• Inflammation Is Necessary for Long-Term but Not Short-Term High-Fat Diet–Induced Insulin Resistance

  2011cited by this paper
• Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia.

  2011cited by this paper
• The role of immunity in Huntington's disease

  2011cited by this paper
• Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.

  2011cited by this paper
• New animal models of Parkinson's disease

  2011cited by this paper
• IGF-1 protects against diabetic features in an in vivo model of Huntington's disease.

  2011cited by this paper
• Diabetes and the Risk of Developing Parkinson’s Disease in Denmark

  2011cited by this paper
• Toll-like receptors: linking inflammation to metabolism.

  2011cited by this paper
• Overweight worsens apoptosis, neuroinflammation and blood-brain barrier damage after hypoxic ischemia in neonatal brain through JNK hyperactivation

  2011influential reference
• Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes

  2011cited by this paper
• Bidirectional association between depression and type 2 diabetes mellitus in women.

  2010cited by this paper
• Neuroinflammation is a key player in Parkinson’s disease and a prime target for therapy

  2010cited by this paper
• Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology.

  2010cited by this paper
• Insulin Levels are Decreased in the Cerebrospinal Fluid of Women with Prodomal Alzheimer's Disease

  2010cited by this paper
• Psychological symptoms and insulin sensitivity in adolescents

  2010cited by this paper
• Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes

  2010cited by this paper
• Insulin resistance and metabolic profile in antipsychotic naïve schizophrenia patients.

  2010cited by this paper
• Insulin metabolism and the risk of Alzheimer disease

  2010cited by this paper
• Macrophages, inflammation, and insulin resistance.

  2010cited by this paper
• A critical review of human endotoxin administration as an experimental paradigm of depression.

  2010cited by this paper
• Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet.

  2010cited by this paper
• Antidepressant Use Before and After the Diagnosis of Type 2 Diabetes

  2010cited by this paper
• Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients

  2010cited by this paper
• Targeting Glial Cells to Elucidate the Pathogenesis of Huntington’s Disease

  2010cited by this paper
• Faculty Opinions recommendation of Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes.

  2010cited by this paper
• Role of glycogen synthase kinase-3 in Alzheimer’s disease pathogenesis and glycogen synthase kinase-3 inhibitors

  2010cited by this paper
• beta-Amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain.

  2010cited by this paper
• Insulin resistance is associated with the pathology of Alzheimer disease

  2010cited by this paper
• Depression and Insulin Resistance

  2010cited by this paper
• β‐Amyloid deposition in brains of subjects with diabetes

  2009cited by this paper
• Neuroinflammation in Parkinson's disease: a target for neuroprotection?

  2009cited by this paper
• Brain glucose transporters, O‐GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer’s disease

  2009cited by this paper
• Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease.

  2009cited by this paper
• The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid.

  2009cited by this paper
• Oxidative Stress in Diabetes and Alzheimer's Disease

  2009cited by this paper
• Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice.

  2009cited by this paper
• Huntington’s Disease Does Not Appear to Increase the Risk of Diabetes Mellitus

  2009cited by this paper
• In vivo electrophysiological effects of insulin in the rat brain.

  2009cited by this paper
• An Integrative View of the Role of Oxidative Stress, Mitochondria and Insulin in Alzheimer's Disease

  2009cited by this paper
• Intracerebroventricular insulin improves spatial learning and memory in male Wistar rats.

  2009cited by this paper
• Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.

  2009cited by this paper
• Neurodegenerative disease: Diabetes, microvascular pathology and Alzheimer disease

  2009cited by this paper
• Insulin is a Two-Edged Knife on the Brain

  2009cited by this paper
• Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes.

  2009cited by this paper
• Insulin Receptor Dysfunction Impairs Cellular Clearance of Neurotoxic Oligomeric Aβ*

  2009cited by this paper
• Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion.

  2009cited by this paper
• Differential Regulation of STAT Family Members by Glycogen Synthase Kinase-3*

  2008cited by this paper
• Alzheimer's Disease is Type 3 Diabetes—Evidence Reviewed

  2008cited by this paper
• Neuroinflammation and Oxidation/Nitration of α-Synuclein Linked to Dopaminergic Neurodegeneration

  2008cited by this paper
• [Glucoregulation in normal weight schizophrenia patients treated by first generation antipsychotics].

  2008cited by this paper
• Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease

  2008cited by this paper
• Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies.

  2008cited by this paper
• Defective insulin signaling pathway and increased glycogen synthase kinase‐3 activity in the brain of diabetic mice: Parallels with Alzheimer's disease and correction by insulin

  2008cited by this paper
• Long-chain polyunsaturated fatty acids modulate interleukin-1beta-induced changes in behavior, monoaminergic neurotransmitters, and brain inflammation in rats.

  2008cited by this paper
• Food restriction and streptozotocin treatment decrease 5-HT1A and 5-HT2A receptor-mediated behavioral effects in rats

  2008cited by this paper
• Insulin, IGF-1, and muscarinic agonists modulate schizophrenia-associated genes in human neuroblastoma cells.

  2008cited by this paper
• Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: findings from the Nutrition and Health of Aging Population in China Study.

  2008cited by this paper
• Insulin resistance and Alzheimer's disease: molecular links & clinical implications.

  2008cited by this paper
• Cholesterol in islet dysfunction and type 2 diabetes.

  2008cited by this paper
• Effect of insulin on the cognizing function and expression of hippocampal A&bgr;1–40 of rat with Alzheimer disease

  2008cited by this paper
• Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias

  2008cited by this paper
• Hepatic insulin resistance in antipsychotic naive schizophrenic patients: stable isotope studies of glucose metabolism.

  2008cited by this paper
• Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion.

  2008cited by this paper
• Interaction between BDNF and Serotonin: Role in Mood Disorders

  2008cited by this paper
• Insulin Dysfunction Induces In Vivo Tau Hyperphosphorylation through Distinct Mechanisms

  2007cited by this paper
• [Depression in patients with type 2 diabetes mellitus--clinical and therapeutical implications].

  2007cited by this paper
• O-GlcNAc modification in diabetes and Alzheimer's disease.

  2007cited by this paper
• Impaired glucose tolerance in first‐episode drug‐naïve patients with schizophrenia

  2007cited by this paper
• Alzheimer-Like Changes in Rat Models of Spontaneous Diabetes

  2007cited by this paper
• Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.

  2007cited by this paper
• The Effect of Borderline Diabetes on the Risk of Dementia and Alzheimer’s Disease

  2007cited by this paper
• Neuroinflammation in Parkinson's patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb.

  2007cited by this paper
• Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia.

  2007cited by this paper
• Intrahippocampal insulin improves memory in a passive-avoidance task in male wistar rats.

  2007cited by this paper
• Diabetes and Parkinsonian Signs in Older Persons

  2007cited by this paper
• Immune reactivity towards insulin, its amyloid and protein S100B in blood sera of Parkinson's disease patients

  2007cited by this paper
• The role of GSK3 in glucose homeostasis and the development of insulin resistance.

  2007cited by this paper

• Lactobacillus acidophilus exerts neuroprotective effects in MPTP mice: potential links to the gut microbiota and GLP-1.

  2026cites this paper
• Intranasal insulin administration improves anxiety- and depressive-like behaviors in PTSD-exposed rats.

  2025cites this paper
• Explainable machine learning-driven models for predicting Parkinson’s disease and its prognosis: obesity patterns associations and models development using NHANES 1999–2018 data

  2025cites this paper
• The bidirectional influence between type 2 diabetes mellitus and the state of depression and anxiety.

  2025cites this paper
• Peripheral Inflammation and Insulin Resistance: Their Impact on Blood–Brain Barrier Integrity and Glia Activation in Alzheimer’s Disease

  2025cites this paper
• Association of waist circumference with all cause mortality in Parkinson’s disease

  2025cites this paper
• Shared interactions of six neurotropic viruses with 38 human proteins: a computational and literature-based exploration of viral interactions and hijacking of human proteins in neuropsychiatric disorders

  2025cites this paper
• Insulin signaling disruption exacerbates memory impairment and seizure susceptibility in an epilepsy model with Alzheimer’s disease-like pathology

  2025cites this paper
• The GLP-1 receptor agonist exenatide improves recovery from spinal cord injury by inducing macrophage polarization toward the M2 phenotype

  2024cites this paper
• Metabolic mysteries of the mind: Investigating type 3 diabetes

  2024cites this paper
• Type 3 Diabetes Mellitus: A Link between Alzheimer's Disease and Type 2 Diabetes Mellitus

  2024cites this paper
• Intermittent fasting and neurodegenerative diseases: Molecular mechanisms and therapeutic potential.

  2024cites this paper
• Insulin potential in preventing brain damage after traumatic brain injury: What we know

  2024cites this paper
• Therapeutic impact of a benzofuran derivative on Aluminium chloride-induced Alzheimer's disease-like neurotoxicity in rats via modulating apoptotic and Insulin 1 genes.

  2024cites this paper
• Metabolic Insights into Neuropsychiatric Illnesses and Ketogenic Therapies: A Transcriptomic View

  2024cites this paper
• Retracted Article: The interaction between insulin resistance and Alzheimer’s disease: a review article

  2024cites this paper
• A computational model of Alzheimer's disease at the nano, micro, and macroscales

  2024cites this paper
• Intranasal insulin intake and exercise improve memory function in amyloid-β induced Alzheimer's-like disease in rats: Involvement of hippocampal BDNF-TrkB receptor.

  2023cites this paper
• Involvement of the Receptor for Advanced Glycation End Products (RAGE) in High Fat-High Sugar Diet-Induced Anhedonia in Rats.

  2023cites this paper
• Combination of UHPLC‐Q Exactive‐Orbitrap MS, Bioinformatics and Molecular Docking to Reveal the Mechanism of Huan‐Lian‐Jie‐Du Decoction in the Treatment of Diabetic Encephalopathy

  2023cites this paper
• A novel protective modality against rotenone-induced Parkinson's disease: A pre-clinical study with dulaglutide.

  2023cites this paper
• Apigetrin-enriched Pulmeria alba extract prevents assault of STZ on pancreatic β-cells and neuronal oxidative stress with concomitant attenuation of tissue damage and suppression of inflammation in the brain of diabetic rats.

  2023cites this paper
• Neurotransmitters in Type 2 Diabetes and the Control of Systemic and Central Energy Balance

  2023cites this paper
• Virgin coconut oil reverses behavioral phenotypes of letrozole-model of PCOS in Wistar rats via modulation of NRF2 upregulation

  2023cites this paper
• Significance of Brain Glucose Hypometabolism, Altered Insulin Signal Transduction, and Insulin Resistance in Several Neurological Diseases

  2022cites this paper
• Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer’s Disease: Review and Meta-Analysis

  2022cites this paper
• The identities of insulin signaling pathway are affected by overexpression of Tau and its phosphorylation form

  2022cites this paper
• The concept of “metabolic jet lag” in the pathophysiology of bipolar disorder: implications for research and clinical care

  2022cites this paper
• Intranasal Peptide Therapeutics: A Promising Avenue for Overcoming the Challenges of Traditional CNS Drug Development

  2022cites this paper
• Zentralnervöse Prozesse bei der Prävention von Typ-2-Diabetes – Ferdinand-Bertram-Preis 2022 – eine Kurzübersicht der Preisträgerin Stephanie Kullmann

  2022cites this paper
• Cinnamaldehyde Regulates Insulin and Caspase-3 Signaling Pathways in the Sporadic Alzheimer’s Disease Model: Involvement of Hippocampal Function via IRS-1, Akt, and GSK-3β Phosphorylation

  2022cites this paper
• Learning and memory impairment and transcriptomic profile in hippocampus of offspring after maternal fructose exposure during gestation and lactation.

  2022cites this paper
• New Therapeutic Approaches to and Mechanisms of Ginsenoside Rg1 against Neurological Diseases

  2022cites this paper
• Design and development of chitosan-insulin-transfersomes (Transfersulin) as effective intranasal nanovesicles for the treatment of Alzheimer's disease: In vitro, in vivo, and ex vivo evaluations.

  2022cites this paper
• Waist circumference and risk of Parkinson’s disease

  2022cites this paper
• Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice

  2022cites this paper
• Protective properties of GLP‐1 and associated peptide hormones in neurodegenerative disorders

  2021cites this paper
• The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children

  2021cites this paper
• Insulin and Insulin Resistance in Alzheimer’s Disease

  2021cites this paper
• Effects of apolipoprotein E isoform, sex, and diet on insulin BBB pharmacokinetics in mice

  2021cites this paper
• Mechanisms of Insulin Resistance at the Crossroad of Obesity with Associated Metabolic Abnormalities and Cognitive Dysfunction

  2021cites this paper
• Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model

  2021cites this paper
• Linsitinib (OSI-906) modulates brain energy metabolism and seizure activity in the lithium-pilocarpine rat model

  2021cites this paper
• Treating cognitive impairment in schizophrenia with GLP-1RAs: an overview of their therapeutic potential

  2021cites this paper
• Evaluation of Effect of Ninjin'yoeito on Regional Brain Glucose Metabolism by 18F-FDG Autoradiography With Insulin Loading in Aged Mice

  2021cites this paper
• Imipramine alleviates memory impairment and hippocampal apoptosis in STZ-induced sporadic Alzheimer's rat model: possible contribution of MAPKs and insulin signaling.

  2021cites this paper
• Role of Insulin Resistance in the Alzheimer's Disease Progression

  2020cites this paper
• Low-dose intranasal insulin improves cognitive function and suppresses the development of epilepsy.

  2020cites this paper
• Insulin BBB pharmacokinetics in young apoE male and female transgenic mice

  2020cites this paper
• Variants in the Upstream Region of the Insulin Receptor Substrate-1 Gene Is Associated with Major Depressive Disorder in the Han Chinese Population

  2020cites this paper
• Brain microRNAs dysregulation: implication for missplicing and abnormal post-translational modifications of tau protein in Alzheimer's disease and related tauopathies.

  2020cites this paper
• Central nervous pathways of insulin action in the control of metabolism and food intake.

  2020cites this paper
• Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics.

  2020cites this paper
• Insulin resistance and bioenergetic manifestations: Targets and approaches in Alzheimer's disease.

  2020cites this paper
• Role of Insulin in Neurotrauma and Neurodegeneration: A Review

  2020cites this paper
• Molecular genetic basis of neurotic disorders. Modern outlooks

  2020cites this paper
• Type 3 Diabetes Mellitus: A Link Between Alzheimer's Disease and Type 2 Diabetes Mellitus

  2020cites this paper
• Determination of Neurodegeneration in Polycystic Ovary Syndrome with Retinal Segmentation Analysis

  2020cites this paper
• Variants in the Upstream Region of the Insulin Receptor Substrate-1 Gene Is Associated with Major Depressive Disorder in the Han Chinese Population

  2020cites this paper
• Variants in the Upstream Region of the Insulin Receptor Substrate-1 Gene Is Associated with Major Depressive Disorder in the Han Chinese Population

  2020cites this paper
• NDT_A_222906 501..507

  2020cites this paper
• Distribution of insulin in trigeminal nerve and brain after intranasal administration

  2019cites this paper
• Brain Metabolic Alterations in Rats Showing Depression-Like and Obesity Phenotypes

  2019cites this paper
• The depressed heart

  2019cites this paper
• Effects of hypertension on cerebral cortical thickness alterations in patients with type 2 diabetes.

  2019cites this paper
• Ablating astrocyte insulin receptors leads to delayed puberty and hypogonadism in mice

  2019cites this paper
• Current and emerging avenues for Alzheimer's disease drug targets

  2019cites this paper
• To be or not to be: PP2A as a dual player in CNS functions, its role in neurodegeneration, and its interaction with brain insulin signaling

  2019cites this paper
• GLP-1 receptor agonists for Parkinson's disease (Protocol)

  2018cites this paper
• Cortical thickness contributes to cognitive heterogeneity in patients with type 2 diabetes mellitus

  2018cites this paper
• GLP-1 receptor agonists for Parkinson's disease.

  2018cites this paper
• Expression of MAPK and Inflammasomes in Brain Cells in Experimental Alzheimer’s Disease

  2018cites this paper
• Insulin resistance and Alzheimer’s disease: the role of defective insulin signaling and inflammation

  2018cites this paper
• Investigating the role of P38, JNK and ERK in LPS induced hippocampal insulin resistance and spatial memory impairment: effects of insulin treatment

  2018cites this paper
• Beyond Hyperglycemia, Evidence for Retinal Neurodegeneration in Metabolic Syndrome.

  2018cites this paper
• Neuroprotective effects of the novel GLP-1 long acting analogue semaglutide in the MPTP Parkinson's disease mouse model.

  2018cites this paper
• Role of GPR40 in pathogenesis and treatment of Alzheimer's disease and type 2 diabetic dementia

  2018cites this paper
• The Effect of Intrahippocampal Insulin Injection on Scopolamine-induced Spatial Memory Impairment and Extracellular Signal-regulated Kinases Alteration

  2018cites this paper
• Two novel dual GLP‐1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease

  2018cites this paper
• Expression of MAPK and inflammasomes in cells of the brain in experimental Alzheimer's disease

  2017cites this paper
• Insulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages

  2017influential citation
• Regulation of insulin receptor phosphorylation in the brains of prenatally stressed rats: New insight into the benefits of antidepressant drug treatment.

  2017cites this paper
• The SAMP8 mouse for investigating memory and the role of insulin in the brain

  2017cites this paper
• Metabolic hormones and physical activity as regulators of brain glial cell functions and neuroimmune status

  2017cites this paper
• Hippocampal insulin resistance and altered food decision-making as players on obesity risk.

  2017cites this paper
• Reduction of Cognitive Decline in Patients with or at High Risk for Diabetes

  2017cites this paper
• A network of insulin peptides regulate glucose uptake by astrocytes: Potential new druggable targets for brain hypometabolism.

  2017cites this paper
• A novel GLP‐1/GIP dual receptor agonist protects from 6‐OHDA lesion in a rat model of Parkinson's disease

  2017cites this paper
• Psychotic Symptoms Associated with Poor Renal Function in Mild Cognitive Impairment and Dementias

  2017cites this paper
• Экспрессия MApK и инфламмасом в клетках головного мозга при экспериментальной болезни Альцгеймера

  2017cites this paper
• A novel GLP‐1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease

  2017cites this paper
• Role of Adiposity-Driven Inflammation in Depressive Morbidity

  2017cites this paper
• Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's disease

  2016cites this paper
• Insulin potentiates the therapeutic effect of memantine against central STZ-induced spatial learning and memory deficit.

  2016cites this paper
• Repurposing of Anti-Diabetic Agents for the Treatment of Cognitive Impairment and Mood Disorders.

  2016cites this paper
• A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF.

  2016cites this paper
• Dietary Long Chain Omega-3 Polyunsaturated Fatty Acids and Inflammatory Gene Expression in Type 2 Diabetes

  2016cites this paper
• Goji fruit (Lycium barbarum) protects sciatic nerve function against crush injury in a model of diabetic stress.

  2016cites this paper
• Association of Depressive and Anxiety Disorders With Diagnosed Versus Undiagnosed Diabetes: An Epidemiological Study of 90,686 Participants

  2016cites this paper
• Expression of β-site APP-cleaving enzyme 1 in the hippocampal tissue of an insulin-resistant rat model of Alzheimer's disease.

  2015cites this paper